The apolipoprotein B Q3405E polymorphism has no effect on its low-density-lipoprotein receptor binding affinity

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Apolipoprotein B100 (apoB100) contains sequences critical for low-density lipoprotein (LDL) receptor binding.
• Polymorphisms and mutations in apoB100 can influence LDL receptor interactions.
• A charge-change polymorphism, Q3405E, was identified in the putative LDL receptor binding domain.

Purpose of the Study:

• To investigate the impact of the Q3405E polymorphism on the binding affinity of LDL to the LDL receptor.
• To determine if an additional negative charge at residue 3405 affects LDL-receptor interactions.

Main Methods:

• DNA sequencing to identify apoB100 polymorphisms.
• Population screening for allele frequency of the Q3405E variant.
• Competitive dual-label fibroblast binding assays and competitive displacement binding assays to assess LDL binding affinity in heterozygous and homozygous individuals.

Main Results:

• The Q3405E polymorphism, resulting from a C-to-G transition, was found in 0.9% of the population.
• Seven heterozygous individuals and one homozygous individual for the glutamate allele were studied.
• The presence of the additional negative charge at residue 3405 had no detectable effect on LDL binding affinity to the LDL receptor.

Conclusions:

• The Q3405E polymorphism in apolipoprotein B100 does not significantly alter the binding affinity of LDL to its receptor.
• Understanding apoB100 sequence variations is crucial for comprehending LDL receptor function.
• Further research may explore other apoB100 variants and their functional consequences.